Message:

<p>[QUOTE=&quot;mrbrklyn, post: 553955, member: 4381&quot;]Actually the rDNA therapies and the ability to grow them in broths is an exciting breakthrough and it is going to have major impact in the near future.&nbsp; You were telling me about them before and you opened up my eyes to how this is currently developing.&nbsp; There are catches though.&nbsp; I went to San Fransisco last year for a weeks worth of meetings and work shops on recombinant anti-bodies and biological developments.&nbsp; The trouble they run into, and this is critical for dosage delivery systems, is that these very biological active compounds are also highly antigenic by design.&nbsp; They are functioning right there at the level of immunological activation and they already had one very very bad clinical trial. </p><p><br /></p><p>Our technology might just not be there yet because to avoid this kind of problem within realistic and practical levels of safety, it might be necessary to build a cocktail mapped directly to the immunological conditions of the patients and rDNA&nbsp; fermentation might go a long way towards that.&nbsp; But there are a lot of hurdles to leap over, not the least of which is that a normal drug is tested on 500 patients in primary clinical trials, and thousands of patients in secondary trials before being released.&nbsp; Here what we are proposing is that each batch is a new and different delivery system going to the patient without ANY trials, and once those slow releasing intracellular mediators get released into the blood stream, all a MD can do is supportive medicine and watch the results with horror.</p><p><br /></p><p>Ruben[/QUOTE]</p><p><br /></p>

Your name or email address:

Do you already have an account?

• No, create an account now.
• Yes, my password is:
• Forgot your password?

Stay logged in